NYSEARCA:LCTX

Lineage Cell Therapeutics, Inc. Stock Predictions

NYSE Arca > Healthcare > Biotechnology

Open Broker Account

$1.05

+0.0400 (+3.96%)

At Close: May 22, 2024

Currently predicting for Thu, 23 May 2024

Trading levels for LCTX

Fibonacci Support & Resistance Levels

		Level	Price
	Resistance	R3	1.14	8.89 %
		R2	1.11	5.43 %
		R1	1.08	3.30 %
Current price:			1.05
	Support	S1	1.01	-3.61 %
		S2	0.99	-5.75 %
		S3	0.95	-9.21 %

Accumulated Volume Support & Resistance Levels

		Level	Price
	Resistance	R3	1.30	23.81 %
		R2	1.29	22.86 %
		R1	1.09	3.81 %
Current price			1.05
	Support	S1	1.04	-0.95%
		S2	1.03	-1.90%
		S3	1.01	-3.81%

LCTX Predictions History

3 years ago
Brian Brown predicted that LCTX for 2020-12-16 is going $5.00 (174.73%)

Rank:

3 years ago
JS predicted that LCTX for 2020-12-08 is going $1.55 (-4.91%)

3 years ago
JesusCoca predicted that LCTX for 2020-12-08 is going

Rank:

About Lineage Cell Therapeutics, Inc.

Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-related macular degeneration; OPC1, an oligodendrocyte progenitor cell therapy that is in Phase I/IIa mul... LCTX Profile

Golden Star

Ticker	Date	Change	Price
LYV	May 16	5.81%	$96.38
CNI	May 16	0.0948%	$126.57
TTWO	May 16	3.66%	$146.08
RL	May 15	0.611%	$166.98
PAGS	May 15	2.20%	$12.74
LNG	May 14	1.54%	$157.42
VGIT	May 14	0.242%	$57.83
VCLT	May 14	0.82%	$75.73
BNDX	May 14	0.309%	$48.60
FIXD	May 14	0.233%	$42.89

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In